From: Optimized strategy for schistosomiasis elimination: results from marginal benefit modeling
Intervention | Abbreviation | Context |
---|---|---|
Risk surveillance | RS | The cost of surveillance in endemic areas, including surveillance human infections, animal infections, snail infections and snail habitats as well as the routine operation of surveillance stations |
Molluscicide for snail control | MSC | The cost of using molluscicides to control or eliminate snails, including the procurement of molluscicides, hiring of labor and renting of equipment for the application of molluscicides |
Treatment | Treat | Government subsidies provided for the diagnosis, medication and supportive care of schistosomiasis patients |
Population chemotherapy | PC | The cost associated with the mass drug administration (MDA) of praziquantel to the population in the endemic area, regardless of whether there are clear symptoms or cases of infection |
Building toilets | BT | The cost of renovating and constructing toilets |
Environmental modification for snail control | EMSC | The cost of snail elimination through physical and biological control measures (such as snail-suppressive forests, irrigation hardening) |
Animal slaughter | AR | The cost of eliminating reservoir hosts (e.g., cattle, sheep, etc.) replaced by machine in endemic areas |
Health education | HE | The cost of disseminating knowledge to the public about the pathogen transmission, disease prevention and promoting community engagement and behavior change interventions |
Livestock chemotherapy | LC | The cost of administering drug therapy to livestock in endemic areas |